The Record

The Orders Library

Name: The COVID Project Orders Library
Creator: The COVID Project

13,511 instruments indexed by The COVID Project: the orders of the fifty States and the District, forty metros, the federal layer and the agencies; the standing duties; the organizers' notices; the legal authorities. Filter by kind, State, limitation type, quarter and more; open the exhibit; download what you find.

Double quotes make a phrase ("stay at home"). An exhibit ID (TX-004) opens its record first.

The COVID Projectcovidproject.com/library

Filters:Collection: Federal health, safety and transport layer Health care orders Clear all

36 instruments · showing 1–25

Sort Per page

Exhibit	Instrument	Issuer	Jurisdiction	Issued	Quarters	Limitations	Grade
Ex. FED-180	Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020)Declaration Under the Public Readiness and Emergency Preparedness Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar.…	Secretary of Health and Human Services	United StatesFederal	Mar. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-181	Determination of Public Health Emergency and Declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for 2019-nCoVDetermination of Public Health Emergency, 85 Fed. Reg. 7316 (Feb. 7, 2020)	Secretary of Health and Human Services	United StatesFederal	Feb. 4, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-160	COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (consolidated document; version updated May 24, 2021)COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers	Centers for Medicare & Medicaid Services, HHS	United States (Medicare, Medicaid and CHIP providers)Federal	Mar. 13, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-096	CMS QSO-20-13-Hospitals (Mar. 4, 2020), QSO-20-14-NH (Mar. 13, 2020), QSO-20-18-HHA (Mar. 10, 2020)QSO-20-13-Hospitals	CMS, Center for Clinical Standards and Quality / Quality, Safety & Oversight Group	United States (Medicare-participating hospitals)Federal	Mar. 4, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-164	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-12-All, Suspension of Survey Activities	CMS, Quality, Safety & Oversight Group	United States (all certified providers, suppliers and CLIA laboratories)Federal	Mar. 4, 2020	2020 Q2	Health care ordersCourts and public offices	Primary source read
Ex. FED-098	QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs)QSO-20-18-HHA	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid home health agencies)Federal	Mar. 10, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-097	QSO-20-14-NH, Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes (Mar. 9, 2020; REVISED Mar. 13, 2020)QSO-20-14-NH (REVISED)	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid nursing homes)Federal	Mar. 13, 2020	2020 Q22020 Q3	Business closureGathering capHealth care orders	Primary source read
Ex. FED-194	Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health EmergencyNotification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency, 85 Fed.…	HHS Office for Civil Rights	United States (HIPAA covered health care providers)Federal	Mar. 17, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-099	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-20-ALL, Prioritization of Survey Activities	CMS, Quality, Safety & Oversight Group	United States (all Medicare/Medicaid certified providers and suppliers; CLIA laboratories)Federal	Mar. 23, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersCourts and public offices	Primary source read
Ex. FED-184	Emergency Use Authorization Declaration: drugs and biological productsEmergency Use Authorization Declaration, 85 Fed. Reg. 18250 (Apr. 1, 2020)	Secretary of Health and Human Services	United StatesFederal	Mar. 27, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Emergency declarationHealth care orders	Primary source read
Ex. FED-090	CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule with comment period)Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 19230…	Centers for Medicare & Medicaid Services, HHS	United States (Medicare and Medicaid providers)Federal	Mar. 30, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-158	CMS, Non-Emergent, Elective Medical Services, and Treatment Recommendations (Apr. 7, 2020) (tiered framework; supplements the Adult Elective Surgery and Procedures Recommendations of Mar. 18, 2020)Non-Emergent, Elective Medical Services, and Treatment Recommendations	Centers for Medicare & Medicaid Services, HHS	United States (all healthcare facilities and clinicians)Federal	Apr. 7, 2020	2020 Q2	Business closureHealth care orders	Primary source read
Ex. FED-159	CMS Recommendations, Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I (Apr. 19, 2020)Opening Up America Again: Centers for Medicare & Medicaid Services (CMS) Recommendations Re-opening Facilities to Provide Non-emergent…	Centers for Medicare & Medicaid Services, HHS	United StatesFederal	Apr. 19, 2020	2020 Q2	Capacity limitHealth care ordersWorkplace rules	Primary source read
Ex. FED-091	CMS-5531-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule)Medicare and Medicaid Programs, Basic Health Program, and Exchanges; Additional Policy and Regulatory Revisions in Response to the COVID-19…	Centers for Medicare & Medicaid Services, HHS	United StatesFederal	May 1, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-161	QSO-20-29-NH and CMS-5531-IFC, 85 Fed. Reg. 27550 (May 8, 2020): 42 C.F.R. 483.80(g) reportingQSO-20-29-NH	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid nursing homes)Federal	May 6, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-157	QSO-20-30-NH, Nursing Home Reopening Recommendations for State and Local Officials (May 18, 2020; REVISED Mar. 10, 2021; expired Mar. 10, 2021)QSO-20-30-NH, Nursing Home Reopening Recommendations for State and Local Officials	CMS, Quality, Safety & Oversight Group	United States (nursing homes; State and local officials)Federal	May 18, 2020	2020 Q22020 Q32020 Q42021 Q1	Capacity limitGathering capHealth care orders	Primary source read
Ex. FED-165	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-31-All (REVISED)	CMS, Quality, Safety & Oversight Group	United StatesFederal	June 1, 2020	2020 Q22020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-166	CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020)QSO-20-35-ALL	CMS, Quality, Safety & Oversight Group	United StatesFederal	Aug. 17, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care orders	Primary source read
Ex. FED-168	CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022)QSO-20-38-NH (Aug. 26, 2020)	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid LTC facilities)Federal	Aug. 26, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersWorkplace rulesQuarantine and isolation	Primary source read
Ex. FED-092	CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022)Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act…	Centers for Medicare & Medicaid Services, HHS	United States (Medicare and Medicaid long-term care facilities; hospitals and CAHs; CLIA laboratories)Federal	Sept. 2, 2020	2020 Q32020 Q42021 Q12021 Q22021 Q3	Health care ordersWorkplace rulesQuarantine and isolation	Primary source read
Ex. FED-154	QSO-20-39-NH, Nursing Home Visitation - COVID-19 (original, Sept. 17, 2020)QSO-20-39-NH, Nursing Home Visitation - COVID-19	CMS, Quality, Safety & Oversight Group	United States (Medicare and Medicaid nursing homes)Federal	Sept. 17, 2020	2020 Q32020 Q42021 Q1	Gathering capHealth care orders	Primary source read
Ex. FED-093	CMS-9912-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule): 42 C.F.R. § 433.400 (FMAP maintenance-of-effort conditions); vaccine coverageAdditional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency, 85 Fed. Reg. 71142 (Nov. 6, 2020)	Centers for Medicare & Medicaid Services, HHS (with Treasury and Labor)	United States (State Medicaid programs; group health plans; providers)Federal	Nov. 2, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-185	Emergency Use Authorization letter: Pfizer-BioNTech COVID-19 Vaccine (Dec. 11, 2020; reissued and amended thereafter)Letter of Authorization, Pfizer-BioNTech COVID-19 Vaccine	Food and Drug Administration, HHS (Center for Biologics Evaluation and Research)	United StatesFederal	Dec. 11, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-186	Emergency Use Authorization letter: Moderna COVID-19 Vaccine (Dec. 18, 2020; reissued thereafter)Letter of Authorization, Moderna COVID-19 Vaccine	Food and Drug Administration, HHS	United StatesFederal	Dec. 18, 2020	2020 Q42021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read
Ex. FED-187	Emergency Use Authorization letter: Janssen COVID-19 Vaccine (Feb. 27, 2021; reissued thereafter; revoked June 1, 2023)Letter of Authorization, Janssen COVID-19 Vaccine	Food and Drug Administration, HHS	United StatesFederal	Feb. 27, 2021	2021 Q12021 Q22021 Q3	Health care ordersOther	Primary source read

Secretary of Health and Human Services, Declaration Under the PREP Act for Medical Countermeasures Against COVID-19, 85 Fed. Reg. 15198 (Mar. 17, 2020; effective Feb. 4, 2020) (Mar. 10, 2020) (Ex. FED-180)
Secretary of Health and Human Services, Determination of Public Health Emergency and Declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for 2019-nCoV (Feb. 4, 2020) (Ex. FED-181)
Centers for Medicare & Medicaid Services, HHS, COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers (consolidated document; version updated May 24, 2021) (Mar. 13, 2020) (Ex. FED-160)
CMS, Center for Clinical Standards and Quality / Quality, Safety & Oversight Group, CMS QSO-20-13-Hospitals (Mar. 4, 2020), QSO-20-14-NH (Mar. 13, 2020), QSO-20-18-HHA (Mar. 10, 2020) (Ex. FED-096)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-164)
CMS, Quality, Safety & Oversight Group, QSO-20-18-HHA, Guidance for Infection Control and Prevention Concerning Coronavirus Disease 2019 (COVID-19) in Home Health Agencies (HHAs) (Mar. 10, 2020) (Ex. FED-098)
CMS, Quality, Safety & Oversight Group, QSO-20-14-NH, Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in Nursing Homes (Mar. 9, 2020; REVISED Mar. 13, 2020) (Ex. FED-097)
HHS Office for Civil Rights, Notification of Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency (Mar. 17, 2020) (Ex. FED-194)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-099)
Secretary of Health and Human Services, Emergency Use Authorization Declaration: drugs and biological products (Mar. 27, 2020) (Ex. FED-184)
Centers for Medicare & Medicaid Services, HHS, CMS-1744-IFC, Medicare and Medicaid Programs; Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule with comment period) (Mar. 30, 2020) (Ex. FED-090)
Centers for Medicare & Medicaid Services, HHS, CMS, Non-Emergent, Elective Medical Services, and Treatment Recommendations (Apr. 7, 2020) (tiered framework; supplements the Adult Elective Surgery and Procedures Recommendations of Mar. 18, 2020) (Ex. FED-158)
Centers for Medicare & Medicaid Services, HHS, CMS Recommendations, Re-opening Facilities to Provide Non-emergent Non-COVID-19 Healthcare: Phase I (Apr. 19, 2020) (Ex. FED-159)
Centers for Medicare & Medicaid Services, HHS, CMS-5531-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule) (May 1, 2020) (Ex. FED-091)
CMS, Quality, Safety & Oversight Group, QSO-20-29-NH and CMS-5531-IFC, 85 Fed. Reg. 27550 (May 8, 2020): 42 C.F.R. 483.80(g) reporting (May 6, 2020) (Ex. FED-161)
CMS, Quality, Safety & Oversight Group, QSO-20-30-NH, Nursing Home Reopening Recommendations for State and Local Officials (May 18, 2020; REVISED Mar. 10, 2021; expired Mar. 10, 2021) (Ex. FED-157)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-165)
CMS, Quality, Safety & Oversight Group, CMS QSO-20-12-All (Mar. 4, 2020), QSO-20-20-All (Mar. 23, 2020), QSO-20-31-All (June 1, 2020), QSO-20-35-ALL (Aug. 17, 2020) (Ex. FED-166)
CMS, Quality, Safety & Oversight Group, CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022) (Ex. FED-168)
Centers for Medicare & Medicaid Services, HHS, CMS-3401-IFC, 85 Fed. Reg. 54820 (Sept. 2, 2020) (42 C.F.R. 483.80(h) testing; 482.42(e) hospital reporting) and QSO-20-38-NH (Aug. 26, 2020; revised through Sept. 23, 2022) (Ex. FED-092)
CMS, Quality, Safety & Oversight Group, QSO-20-39-NH, Nursing Home Visitation - COVID-19 (original, Sept. 17, 2020) (Ex. FED-154)
Centers for Medicare & Medicaid Services, HHS (with Treasury and Labor), CMS-9912-IFC, Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency (interim final rule): 42 C.F.R. § 433.400 (FMAP maintenance-of-effort conditions); vaccine coverage (Nov. 2, 2020) (Ex. FED-093)
Food and Drug Administration, HHS (Center for Biologics Evaluation and Research), Emergency Use Authorization letter: Pfizer-BioNTech COVID-19 Vaccine (Dec. 11, 2020; reissued and amended thereafter) (Ex. FED-185)
Food and Drug Administration, HHS, Emergency Use Authorization letter: Moderna COVID-19 Vaccine (Dec. 18, 2020; reissued thereafter) (Ex. FED-186)
Food and Drug Administration, HHS, Emergency Use Authorization letter: Janssen COVID-19 Vaccine (Feb. 27, 2021; reissued thereafter; revoked June 1, 2023) (Ex. FED-187)

The Orders Library

Results